We all know what we mean by treatment-resistant depression - don't we?

被引：11
|
作者：
Anderson, Ian M. [1 ,2 ]
机构：
[1] Univ Manchester, Div Neurosci & Expt Psychol, Neurosci & Psychiat Unit, Room G809,Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England
[2] Manchester Acad Hlth Sci Ctr, Room G809,Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England
来源：
BRITISH JOURNAL OF PSYCHIATRY | 2018年 / 212卷 / 05期
关键词：
Antidepressants; depressive disorders; nosology; diagnosis; placebo; DEFINITION; EFFICACY;
D O I：
10.1192/bjp.2018.56
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
Although in common use, treatment-resistant depression is unhelpful both conceptually and practically. In this issue a new term, multiple-therapy-resistant major depressive disorder, is proposed; although it may be useful in guiding treatment options for patients with persisting depression, it should not be an automatic trigger for further, more invasive treatments.
引用
收藏
页码：259 / 261
页数：3
相关论文
共 50 条
  • [21] Vestibular Schwannoma: What We Know and Where We are Heading
    Vinay Kumar Gupta
    Arjuna Thakker
    Keshav Kumar Gupta
    Head and Neck Pathology, 2020, 14 : 1058 - 1066
  • [22] Do We Know What We Love When We Say that We Love International Organizations?
    Reinisch, August
    INTERNATIONAL ORGANIZATIONS LAW REVIEW, 2024, 21 (03) : 432 - 439
  • [23] Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
    Boziki, Marina Kleopatra
    Kesidou, Evangelia
    Theotokis, Paschalis
    Mentis, Alexios-Fotios A.
    Karafoulidou, Eleni
    Melnikov, Mikhail
    Sviridova, Anastasia
    Rogovski, Vladimir
    Boyko, Alexey
    Grigoriadis, Nikolaos
    BRAIN SCIENCES, 2020, 10 (04)
  • [24] Vestibular Schwannoma: What We Know and Where We are Heading
    Gupta, Vinay Kumar
    Thakker, Arjuna
    Gupta, Keshav Kumar
    HEAD & NECK PATHOLOGY, 2020, 14 (04) : 1058 - 1066
  • [25] Vulvodynia: What We Know and Where We Should Be Going
    Havemann, Logan M.
    Cool, David R.
    Gagneux, Pascal
    Markey, Michael P.
    Yaklic, Jerome L.
    Maxwell, Rose A.
    Iyer, Ashvin
    Lindheim, Steven R.
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2017, 21 (02) : 150 - 156
  • [26] Melanoma overdiagnosis: What do we know and what do we do?
    Clark, Simon
    Rosendahl, Nikita
    Rosendahl, Cliff
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2024, 53 (09) : 612 - 616
  • [27] Targeting repetitive transcranial magnetic stimulation in depression: do we really know what we are stimulating and how best to do it?
    Fitzgerald, Paul B.
    BRAIN STIMULATION, 2021, 14 (03) : 730 - 736
  • [28] Yttrium-90 Radioembolization for Hepatocellular Carcinoma: What We Know and What We Need to Know
    Kim, Yun Hwan
    Kim, Do Young
    ONCOLOGY, 2013, 84 : 34 - 39
  • [29] Depression in maintenance hemodialysis patients: What do we need to know?
    Li, Yulu
    Zhu, Bin
    Shen, Jianqin
    Miao, Liying
    HELIYON, 2023, 9 (09)
  • [30] Advanced gastric cancer: what we know and what we still have to learn
    Federico Coccolini
    Giulia Montori
    Marco Ceresoli
    Simona Cima
    Maria Carla Valli
    Gabriela E Nita
    Arianna Heyer
    Fausto Catena
    Luca Ansaloni
    World Journal of Gastroenterology, 2016, 22 (03) : 1139 - 1159
12345